Structured Summary
Abstract
A chimeric murine-human monoclonal antibody that functions as an INTERLEUKIN 2 RECEPTOR antagonist by binding to the alpha chain (CD25 ANTIGEN) of the interleukin-2 receptor on the surface of activated T-LYMPHOCYTES. It is used in the prevention of acute graft rejection episodes in patients undergoing renal transplantation.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
3 entry terms
- CHI 621
- SDZ CHI 621
- Simulect
MeSH Record
Aspects Covered
24 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2019 (1998)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Basiliximab. Medical Subject Headings (MeSH). 2026. Unique ID D000077552. http://id.nlm.nih.gov/mesh/2026/D000077552
- Basiliximab. In: Wikipedia. https://en.wikipedia.org/wiki/Basiliximab
- Basiliximab. In: Wikidata. https://www.wikidata.org/wiki/Q418702